Bacterial and human peptidylarginine deiminases: targets for inhibiting the autoimmune response in rheumatoid arthritis?

Journal article

Peptidylarginine deiminases (PADs) convert arginine within a peptide (peptidylarginine) into peptidylcitrulline. Citrullination by human PADs is important in normal physiology and inflammation. Porphyromonas gingivalis, a major pathogen in periodontitis, is the only prokaryote described to possess PAD. P. gingivalis infection may generate citrullinated peptides, which trigger anti-citrullinated peptide antibodies. In susceptible individuals, host protein citrullination by human PADs in the joint probably perpetuates antibody formation, paving the way for the development of chronic arthritis. Blockades of bacterial and human PADs may act as powerful novel therapies by inhibiting the generation of the antigens that trigger and sustain autoimmunity in rheumatoid arthritis.

Authors: Mangat, P; Wegner, N; Venables, P; Potempa, J

• Publication status: Published
• Journal: Arthritis research and therapy
• Volume: 12
• Issue: 3
• Pages: 209
• Publication date: 2010-01-01
• DOI: 10.1186/ar3000
• EISSN: 1478-6362
• ISSN: 1478-6354
• Language: English
• Keywords: Amino Acid Sequence; Porphyromonas gingivalis; Autoimmunity; Humans; Risk Factors; Animals; Hydrolases; Molecular Sequence Data; Periodontitis; Arthritis, Rheumatoid